Gossamer Bio Total Current Assets History

Key Indicators . Total Current Assets . Stocks . USA . 
Stock . Gossamer Bio
GOSS Stock  USD 0.36  -0.01  -2.70%   
Total Current Assets stood at 167.6 M as of December 31, 2025. This metric is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Over the last 16 observed reporting periods, this metric has increased at a moderate pace, with partial explanatory fit (R² 0.52) in the linear model. All Reported Financials
 
Total Current Assets  
 First Reported
2017-12-31
 Previous Quarter
204 M
 Current Value
167.6 M
 Quarterly Volatility
146.9 M
Macro event markers
 
Covid
 
Interest Hikes

Latest Gossamer Bio Total Current Assets Growth Pattern

Total Current Assets10 Years Trend
Moderate Growth
   Total Current Assets   
       Timeline  

Total Current Assets Trend Statistics

A CV of 106.6% for Gossamer Bio's Total Current Assets indicates wide dispersion driven primarily by directional growth rather than instability over 10 periods. The R-squared value of 0.52 is consistent with a moderate linear trend with partial explanatory power.
Arithmetic Mean 165,986,287
Geometric Mean 6,122,969
Coefficient Of Variation 106.58
Mean Deviation 156,120,623
Median 167,644,000
Standard Deviation 176,902,534
Sample Variance31294.5T
Range522.3M
R-Value 0.72
Mean Square Error16057.6T
R-Squared 0.52
Significance 0.0011
Slope 25,236,515
Total Sum of Squares500712.1T

Gossamer Bio Total Current Assets History

The historical record covers 10 periods of Gossamer Bio's Total Current Assets from 2017 (445 K) to 2026 (279.6 M).
2026279.6 M
2025167.6 M
2024309.9 M
2023306.5 M
2022261.9 M
2021331.8 M
2020522.3 M
2019409.3 M
2018232 M
2017445 K

Correlation of Total Current Assets With Other Accounts

Below are pairwise correlations of Gossamer Bio's Total Current Assets with other financial line items. Coefficients range from −1 (perfect inverse) to +1 (perfect co-movement). These values describe historical association and do not imply causation.
Click cells to compare fundamentals

Related Fundamentals

Last ReportedEnd Of Year Estimate
Other Current Liabilities56.5 M28.6 M
Total Current Liabilities63.4 M38.1 M
Non Current Assets Total4.6 M8.8 M
Non Current Assets Other408 K794.2 K
Non Current Liabilities Total231.6 M178.8 M
Other Current Assets18.2 M19.1 M
Non Current Liabilities Other229 M140.9 M
Current Deferred Revenue15.3 M13.6 M
Current Ratio 2.64 5.27

Methodology, Assumptions & Data Sources

The historical progression of Gossamer Bio's Total Current Assets is shown below. Cross-referencing this metric with adjacent financial statement accounts provides additional explanatory context. Gossamer Bio's Total Current Assets is shaped by investment and capital allocation patterns characteristic of the Biotechnology sector.

Gossamer Bio analytics rely on periodic company reporting and market reference feeds, with quality checks and normalization applied. Reference data and historical patterns are presented and do not constitute an investment recommendation or advice.

Editorial review and methodology oversight provided by: Rifka Kats, Member of Macroaxis Editorial Board
Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.